- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 02.10. | Stenocare A/S: STENOCARE provides update on future supply of Bedrocan medical cannabis products | 173 | GlobeNewswire (Europe) | STENOCARE A/S
NASDAQ FIRST NORTH GROWTH MARKET, DENMARK
TICKER: STENO
This information is information that STENOCARE A/S is obliged to publish in accordance with the EU Market Abuse Regulation. The... ► Artikel lesen | |
| 21.09. | STENOCARE A/S: Danish Medicines Agency publishes annual medical cannabis safety report - no new safety signals identified | 1 | Cision News | ||
| STENOCARE Aktie jetzt für 0€ handeln | |||||
| 07.09. | Stenocare A/S: Germany's DKK 8.5 billion medical cannabis market in continued uncertainty over the new reimbursement rules | 360 | GlobeNewswire (Europe) | STENOCARE A/S
NASDAQ FIRST NORTH GROWTH MARKET, DENMARK
TICKER: STENOWith this market update, STENOCARE A/S aims to provide its current understanding of the latest developments in the German medical... ► Artikel lesen | |
| 20.08. | Stenocare A/S: STENOCARE reports first-half results with continued momentum: Q2 sales rise 33% over Q1 with fifth consecutive EBITDA-positive quarter | 194 | GlobeNewswire (Europe) | STENOCARE A/S
NASDAQ FIRST NORTH GROWTH MARKET, DENMARK
TICKER: STENO
STENOCARE A/S ("STENOCARE") today announces its results for the period 01.01.2026 - 30.06.2026. The report, which has not been... ► Artikel lesen | |
| 07.08. | Stenocare A/S: France reaches important milestone towards permanent legalisation of medical cannabis | 179 | GlobeNewswire (Europe) | STENOCARE A/S
NASDAQ FIRST NORTH GROWTH MARKET, DENMARK
TICKER: STENO
STENOCARE A/S (STENOCARE) provides an update on the regulatory development of the French medical cannabis programme. The long-awaited... ► Artikel lesen | |
| 03.07. | Stenocare A/S: STENOCARE completes integration of CannGros ApS | 235 | GlobeNewswire (Europe) | STENOCARE A/S
NASDAQ FIRST NORTH GROWTH MARKET, DENMARK
TICKER: STENO
STENOCARE A/S ("STENOCARE") is pleased to announce that the integration of CannGros ApS, acquired in November 2025, has now been... ► Artikel lesen | |
| 07.05. | Stenocare A/S Q1 Loss Decreases | 1 | RTTNews | ||
| 07.05. | Stenocare A/S: Interim report first quarter 2026 | 372 | GlobeNewswire (Europe) | STENOCARE A/S
NASDAQ FIRST NORTH GROWTH MARKET, DENMARK
TICKER: STENOSTENOCARE A/S ("STENOCARE") today announces its results for the period 01.01.2026 - 31.03.2026. The report, which has not been reviewed... ► Artikel lesen | |
| 29.04. | Stenocare A/S: Communiqué from Annual General Meeting | 220 | GlobeNewswire (Europe) | STENOCARE A/S
NASDAQ FIRST NORTH GROWTH MARET, DENMARK
TICKER: STENO
On 29 April 2026 annual general meeting of shareholders of STENOCARE A/S, CVR no. 39024705, was held at Lund Elmer Sandager Law... ► Artikel lesen | |
| 26.02. | Stenocare A/S: Interim report fourth quarter and Financial Statement Release 2025 | 228 | GlobeNewswire (Europe) | STENOCARE A/S
NASDAQ FIRST NORTH GROWTH MARKET, DENMARK
TICKER: STENO
STENOCARE A/S ("STENOCARE") today announces its results for the period 01.01.2025 - 31.12.2025. The report, which has not been... ► Artikel lesen | |
| 11.02. | Stenocare A/S: STENOCARE A/S positions for First-Mover Advantage in France With Strategic Partnership, Product Filing, and National Distribution Partnership | 245 | GlobeNewswire (Europe) | STENOCARE A/S
NASDAQ FIRST NORTH GROWTH MARKET, DENMARK
TICKER: STENO
STENOCARE A/S ("STENOCARE") has entered a strategic partnership with Institut des Cannabinoïdes Médicaux Français (="ICMF") to... ► Artikel lesen | |
| 27.01. | Stenocare A/S: Stenocare Kicks Off Strategic Partnership with WEECO to Launch New Astrum Oil Product in Germany | 528 | GlobeNewswire (Europe) | STENOCARE A/S
NASDAQ FIRST NORTH GROWTH MARKET, DENMARK
TICKER: STENO
Stenocare Enters Strategic Partnership with WEECO Pharma GmbH to Launch Premium Medical Cannabis Oils in Germany. The first new... ► Artikel lesen | |
| 17.11.25 | Stenocare A/S: STENOCARE A/S acquires CannGros ApS and add DKK 4-6 million in annual revenue and supports 2026 break even goal | 285 | GlobeNewswire (Europe) | STENOCARE A/S
NASDAQ FIRST NORTH GROWTH MARKET, DENMARK
TICKER: STENO
This information is information that STENOCARE A/S is obliged to publish in accordance with the EU Market Abuse Regulation. The... ► Artikel lesen |
13 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| AURORA CANNABIS | 3,498 | -1,30 % | Curaleaf Holdings, Inc.: Curaleaf Challenges Aurora's Unilateral Rejection of Its Enhanced Proposal | STAMFORD, Conn., Oct. 19, 2026 /CNW/ -- Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer... ► Artikel lesen | |
| ABBVIE | 253,30 | -0,28 % | AbbVie Announces Topline Results from the Phase 3 INTREPID Trial Showing Lutikizumab Significantly Improved Signs and Symptoms of Disease in Patients with Hidradenitis Suppurativa | In the Phase 3 INTREPID study, lutikizumab achieved the primary endpoint of Hidradenitis Suppurativa Clinical Response 75 (HiSCR75) at Week 16 compared with placebo1
... ► Artikel lesen | |
| CANOPY GROWTH | 0,597 | +1,19 % | Canopy Growth Corp (2): Canopy Growth to release fiscal Q2 results Nov. 6 | ||
| TILRAY BRANDS | 2,585 | -0,96 % | Tilray Brands, Inc.: West Ham United F.C. and BrewDog Unveil Boleyn Brew: A Fan-Created Matchday Beer Made by Hammers, for Hammers | ELLON, Scotland and LONDON, Oct. 21, 2026 (GLOBE NEWSWIRE) -- BrewDog, a leader in U.K. craft beer and one of the world's most recognised beer brands, owned by Tilray Brands, Inc. (NASDAQ: TLRY... ► Artikel lesen | |
| INNOCAN PHARMA | 1,175 | 0,00 % | Innocan Pharma Corporation: Was der Deal jetzt ändert | ||
| TAAT GLOBAL ALTERNATIVES | 0,136 | -100,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.10.2026 -2- | The following instruments on Boerse Frankfurt do have their last trading day on 02.10.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.10.2026ISIN NameCA83013Q8719 CORE... ► Artikel lesen | |
| DERMAPHARM | 38,450 | -0,65 % | JEFFERIES stuft Dermapharm auf 'Hold' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Dermapharm nach einem Treffen mit dem Finanzchef Christof Dreibholz mit einem Kursziel von 44 Euro auf "Hold" belassen.... ► Artikel lesen | |
| CRONOS GROUP | 3,034 | -1,24 % | Cronos Group Inc: Cronos Group completes CanAdelaar acquisition | ||
| SYNBIOTIC | 0,154 | -5,75 % | EQS-Adhoc: SYNBIOTIC SE: Antrag auf Eröffnung eines Insolvenzverfahrens | EQS-Ad-hoc: SYNBIOTIC SE / Schlagwort(e): Insolvenz
SYNBIOTIC SE: Antrag auf Eröffnung eines Insolvenzverfahrens
16.10.2026 / 16:13 CET/CEST
Veröffentlichung einer Insiderinformation... ► Artikel lesen | |
| DIGICANN VENTURES | 0,006 | 0,00 % | XFRA VY3: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| ORGANIGRAM GLOBAL | 0,811 | 0,00 % | Aurora Cannabis: Organigram funkt Curaleaf dazwischen | ||
| GREEN THUMB INDUSTRIES | 5,950 | +2,41 % | President Trump's Push to Reschedule Marijuana Hit a Snag. Is Green Thumb Still a Buy? | ||
| SNDL | 1,140 | -1,30 % | Immortal Dragons: Sundial Initiative Advisor Boyang Wang Sponsors Nakauchi Lab's Work on "Bodyoids" | SINGAPORE, SG / ACCESS Newswire / July 30, 2026 / Boyang Wang, advisor to the Sundial Initiative and founder and CEO of the longevity fund Immortal Dragons, has sponsored the Nakauchi Lab, led by stem... ► Artikel lesen | |
| CRESCO LABS | 0,577 | +2,49 % | Cresco Labs Inc: Cresco Labs to release Q3 2026 results Nov. 6 | ||
| NOVERIS HEALTH SCIENCES | 0,029 | 0,00 % | Noveris Health Sciences Inc.: Noveris Health Sciences Announces Results of 2026 Annual General and Special Meeting | Vancouver, British Columbia--(Newsfile Corp. - September 9, 2026) - Noveris Health Sciences Inc. (CSE: NVRS) (FSE: 0NF1) (OTC Pink: MYCOF) (the "Company" or "Noveris") announces the results of its annual... ► Artikel lesen |
Das Unternehmen STENOCARE A/S kann der Branche Pharma zugeordnet werden. Der aktuelle Kurs liegt bei 0,086 Euro und damit +3,12 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu STENOCARE A/S finden Sie auf Wallstreet Online.